The Pediatric Infectious Disease Journal

Journal

Publication Venue For

  • Gastrointestinal Manifestations in Hospitalized Children with Acute SARS-CoV-2 Infection and Multisystem Inflammatory Condition: An Analysis of the VIRUS COVID-19 Registry.  41:751-758. 2022
  • Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants.  41:E81-E86. 2022
  • Congenital Cytomegalovirus and Hepatic Failure: An Underrecognized Complication.  41:E49-E53. 2022
  • An Adolescent With Neurobrucellosis Caused by Brucella abortus Cattle Vaccine Strain RB51.  40:E353-E355. 2021
  • Two Cases of Cronobacter Sakazakii Meningitis in Infants: The Importance Of Early Advanced Brain Imaging and Public Health Reporting.  40:E346-E348. 2021
  • Neonatal brain injury from sars-cov-2: Fact or fiction?.  40:E266-E267. 2021
  • A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults.  39:345-351. 2020
  • New Strategy Is Needed to Prevent Pneumococcal Meningitis.  39:298-304. 2020
  • Cytomegalovirus Seroprevalence and Birth Prevalence of Congenital CMV Infection in Bosnia and Herzegovina: A Single-Center Experience.  39:140-144. 2020
  • Severe neonatal coronavirus disease 2019 presenting as acute respiratory distress syndrome.  E367-E369. 2020
  • Area deprivation as a risk factor for methicillin-resistant Staphylococcus aureus infection in pediatric cystic fibrosis.  38:E285-E289. 2019
  • Utility of surface and blood polymerase chain reaction assays in identifying infants with neonatal herpes simplex virus infection.  38:1138-1140. 2019
  • Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?.  38:S60-S63. 2019
  • A physician's recommendation for human papillomavirus vaccination.  37:E222-E225. 2018
  • The epidemiology of healthcare-associated infections in pediatric cardiac intensive care units.  37:768-772. 2018
  • Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants.  37:627-631. 2018
  • Fulminant Haemophilus Influenzae Type a Infection in a 4-year-old with Previously Undiagnosed Asplenic Heterotaxy.  37:e108-e110. 2018
  • Predictors of Infant Hepatitis B Immunization in Cameroon: Data to Inform Implementation of a Hepatitis B Birth Dose.  37:103-107. 2018
  • Late-onset Sepsis in Extremely Premature Infants: 2000-2011.  36:774-779. 2017
  • Congenital Cytomegalovirus Infection and Permanent Hearing Loss in Rural North Indian Children.  36:670-673. 2017
  • Methicillin-resistant Staphylococcus aureus as a Cause of Lemierre's Syndrome.  36:429-431. 2017
  • Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adults.  35:1333-1335. 2016
  • Rilpivirine pharmacokinetics without and with darunavir/ritonavir once daily in adolescents and young adults.  35:e271-e274. 2016
  • Clinical predictors of sensorineural hearing loss and cognitive outcome in infants with symptomatic congenital cytomegalovirus infection.  35:924-926. 2016
  • Urine collection method for the diagnosis of congenital cytomegalovirus infection.  34:903-905. 2015
  • Comparison of saliva PCR assay versus rapid culture for detection of congenital cytomegalovirus infection.  34:536-537. 2015
  • Prevalence of congenital cytomegalovirus infection in Nigeria: A pilot study.  34:322-324. 2015
  • Safety, pharmacokinetics and efficacy of dolutegravir in treatment-experienced HIV-1 infected adolescents : Forty-eight-week results from IMPAACT P1093.  34:1207-1213. 2015
  • Etiology of childhood diarrhea after rotavirus vaccine introduction: A prospective, population-based study in Nicaragua.  33:1156-1163. 2014
  • Mycoplasma pneumoniae infections in childhood.  33:92-94. 2014
  • Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: A collaborative analysis of treatment programs.  33:608-616. 2014
  • Immunogenicity of haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants.  32:1400-1402. 2013
  • Genotypic diversity and mixed infection in newborn disease and hearing loss in congenital cytomegalovirus infection.  32:1050-1054. 2013
  • Nonvirologic algorithms for predicting HIV infection among HIV-exposed infants younger than 12 weeks of age.  32:151-156. 2013
  • Decrease in varicella incidence after implementation of the 2-dose recommendation for varicella vaccine in New Hampshire.  32:981-983. 2013
  • Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population.  30:1043-1046. 2011
  • Changes in childhood diarrhea incidence in Nicaragua following 3 years of universal infant rotavirus immunization.  30:243-247. 2011
  • Frequency of ureaplasma serovars in respiratory secretions of preterm infants at risk for bronchopulmonary dysplasia.  30:379-383. 2011
  • Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis.  30:860-865. 2011
  • Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia.  29:849-854. 2010
  • Heptavalent pneumococcal conjugate vaccine immunogenicity in very-low-birth-weight, premature infants.  29:600-606. 2010
  • Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy Urban adolescents in the United States.  29:530-534. 2010
  • Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.  29:195-198. 2010
  • Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: A strong indicator of underlying HIV infection.  29:346-351. 2010
  • Survey of nonsusceptible nasopharyngeal streptococcus pneumoniae isolates in children attending day-care centers in Brazil.  29:77-79. 2010
  • Cytomegalovirus blood viral load and hearing loss in young children with congenital infection.  28:588-592. 2009
  • Cytomegalovirus shedding and delayed sensorineural hearing loss: Results from longitudinal follow-up of children with congenital infection.  28:515-520. 2009
  • Emerging macrolide resistance in mycoplasma pneumoniae in children: Detection and characterization of resistant isolates.  28:693-696. 2009
  • Research priorities to reduce global mortality from newborn infections by 2015.  28. 2009
  • Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.  28:159-161. 2009
  • Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India.  27:841-843. 2008
  • Pseudomonas aeruginosa axillary lymphadenitis in a toddler.  27:950. 2008
  • Polymicrobial catfish spine infection in a child [4].  25:281-282. 2006
  • Diagnosis of herpes simplex virus in the era of polymerase chain reaction.  25:841-842. 2006
  • GB virus C infection in children with perinatal human immunodeficiency virus infection.  24:417-422. 2005
  • Critical appraisal of the role of Ureaplasma in the development of bronchopulmonary dysplasia with metaanalytic techniques.  24:1033-1039. 2005
  • Efficacy, tolerability and pharmacokinetics of two nelfinavir-based regimens in human immunodeficiency virus-infected children and adolescents: Pediatric AIDS Clinical Trials Group Protocol 403.  24:880-885. 2005
  • Long term tolerability and safety af enfuvirtide for human immunodeficiency virus 1-infected children.  23:713-718. 2004
  • Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.  22:335-340. 2003
  • Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis..  22:335-341. 2003
  • Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.  22:239-244. 2003
  • Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients..  22:239-244. 2003
  • Foodborne disease outbreaks in United States schools.  21:623-628. 2002
  • Hypothermia as a risk factor for pediatric cardiothoracic surgical site infection.  20:459-462. 2001
  • Oral oseltamivir treatment of influenza in children.  20:127-133. 2001
  • Viral etiologies of encephalitis in Thai children.  20:216-218. 2001
  • Erratum: Oral oseltamivir treatment of influenza in children (Pediatric Infectious Disease Journal (february 20001) 20:2 (127-133)).  20:421. 2001
  • Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants.  20:746-751. 2001
  • Human antibodies to pneumococcal surface protein A in health and disease.  19:134-138. 2000
  • Clinical significance of enteroviruses in serious summer febrile illnesses of children.  18:869-874. 1999
  • Human herpesviruses 6 and 7: Identification of newly recognized viral pathogens and their association with human disease.  17:59-68. 1998
  • Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants.  17:593-598. 1998
  • Cefprozil treatment of persistent and recurrent acute otitis media.  16:471-478. 1997
  • Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types.  16:409-411. 1997
  • Microbiology testing and the pediatrician's office.  16:339-345. 1997
  • Clinical applications of C-reactive protein in pediatrics.  16:735-747. 1997
  • Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial.  15:247-254. 1996
  • Primary meningococcal pneumonia in a nineteen-month-old child.  14:155-156. 1995
  • Erythromycin lactobionate toxicity in preterm neonates.  13:164-166. 1994
  • Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection.  13:1139-1142. 1994
  • Neonatal herpes simplex virus infections: Is there a role for immunoglobulin in disease prevention and therapy ?.  13:432-439. 1994
  • Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.  13:287-293. 1994
  • Antibiotic susceptibilities and therapeutic options for ureaplasma urealyticum infections in neonates.  11:23-29. 1992
  • Commentary: is there a role for prenatal diagnosis of congenital cytomegalovirus infection?.  11:608-609. 1992
  • Management of rfcurrency of herpes simplex virus infection in young infants.  11:249. 1992
  • Prenatal diagnosis of congenital cytomegalovirus infection by virus isolation after amniocentesis.  11:605-609. 1992
  • Symptomatic congenital cytomegalovirus infection: Neonatal morbidity and mortality.  11:93-99. 1992
  • Congenital toxoplasmosis occurring in infants perinatally infected with human immunodeficiency virus 1.  9:512-518. 1990
  • Increased rate of cytomegalovirus infection among day care center workers.  9:465-470. 1990
  • Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population.  9:241-245. 1990
  • A concurrent epidemic of respiratory syncytial virus and echovirus 7 infections in an intensive care nursery.  8:24-29. 1989
  • Once daily cefadroxil therapy for pyoderma.  8:648-649. 1989
  • Varicella–zoster virus infections: Chronic disease in the immunocompromised host: Evidence for persistent excretion of virus.  8:584-585. 1989
  • Does Ureaplasma urealyticum cause respiratory disease in newborns?.  7:535-541. 1988
  • Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child.  7:289-292. 1988
  • Consensus: Management of the patient with herpes simplex encephalitis.  6:2-5. 1987
  • Role of ureaplasma urealyticum in amnionitis.  5:S247-S252. 1986
  • Ureaplasma urealyticum and its possible role in pneumonia during the neonatal period and infancy.  5:S288-S291. 1986
  • International Standard Serial Number (issn)

  • 0891-3668
  • Electronic International Standard Serial Number (eissn)

  • 1532-0987